Gains USFDA Tentative Nod for Cancer Drug with $259M Market Size
Alembic Pharmaceuticals Ltd · APLLTD · BSE ·
• Received tentative approval from the US Food & Drug Administration (USFDA) for Binimetinib Tablets, 45 mg. • The product targets an estimated market size of US$ 259 million. • As the sole first applicant, the company may be eligible for 180 days of marketing exclusivity upon re…